Events

Loading Events

Past Events

Events Search and Views Navigation

Event Views Navigation

November 2020

Live Webinar: GARDP/REVIVE – Saving childrens’ lives – treating neonatal sepsis

November 20, 2020 @ 4:30 am - 6:00 am

Speakers: Prof Hanan Balkhy, Assistant Director-General for Antimicrobial resistance, WHO Dr Manica Balasegaram, Executive Director, GARDP - Dr Dhanya Dharmapalan, paediatrician and member of the Pediatric Infectious Disease Society (PIDS), Mumbai Dr Borna Nyaoke, Senior Clinical Project Manager, DNDi/GARDP Kenya Moderator: Dr Peter Beyer, Senior Advisor, AMR Division, WHO The presentations will be followed by a Q&A session. The webinar, organized in collaboration with WHO, is being held on the occasion of Universal Children’s Day and during World Antimicrobial Awareness…

Find out more »

World Vaccine and Immunotherapy Congress West Coast 2020

November 30, 2020 - December 3, 2020
Virtual Event, 765 Commonwealth Avenue
Boston, MA 02215 United States
+ Google Map

In December 2019 SARS-CoV-2 the cause of COVID-19, was responsible for thousands of deaths in Wuhan, China. By March 11, 2020, WHO declared COVID-19 as a worldwide pandemic.The single most effective way to tackle this pandemic is a working vaccine, which is why Vaccine Congress West Coast is bringing together experts who have been working tirelessly to make this happen, in a safe, virtual environment. This is the most important meeting you will be part of. Now more than ever,…

Find out more »

December 2020

Global AMR Hub Virtual Conference

December 2, 2020
VIRTUAL EVENT

Translating AMR R&D mapping into policy and action. The Global AMR R&D Hub, through its Dynamic Dashboard, is the global knowledge centre for AMR R&D. The Dynamic Dashboard captures and presents: AMR R&D investments from across the globe and One Health sectors; what new antibacterials are in the pipeline; and what is being done to overcome the challenges hindering the development of, and access to and stewardship of, priority antibacterials. The important next step for the Global AMR R&D Hub…

Find out more »

Infectious Diseases Virtual Partnering

December 2, 2020 - December 4, 2020
VIRTUAL EVENT

Infectious diseases have always impacted human history, but in the past 50 years we have managed to control or eliminate some infectious diseases through improved hygiene, vaccination, antimicrobials, advances in medicine and public health policies. However, the current pandemic is a reminder that we need to continue to pursue our efforts to control these pathogens, especially with intercontinental travel and increased mobility of people and animals. To manage infectious diseases, we use tools such as vaccines, antibiotics, antivirals, diagnostic tools…

Find out more »

Evidence to Action Webinar: Advancing the Antimicrobial Resistance agenda during a pandemic

December 3, 2020 @ 3:00 am - 4:30 am
Virtual Event, 765 Commonwealth Avenue
Boston, MA 02215 United States
+ Google Map

How can efforts to implement Antimicrobial Resistance National Action Plans still progress despite the COVID-19 pandemic? There is no doubt COVID-19 currently represents the most obvious and urgent issue for global health security and the world is rightfully focused on tackling this pandemic. However, the challenges posed by COVID-19 are only a foretaste of what antimicrobial resistance (AMR) can mean to the world without appropriate interventions. AMR, the silent pandemic, can impact many of the global health achievements of past…

Find out more »

Milken Institute Future of Health Summit

December 7, 2020 - December 10, 2020
Webinar

The Milken Institute Future of Health Summit convenes the best minds in the world to confront the most significant health challenges by matching human, financial, scientific, and educational resources with innovative and impactful ideas. The Summit will focus on the converging crises of public health, economic insecurity, and social injustice. COVID-19 has exposed weaknesses across our health systems, particularly in the treatment of our most vulnerable communities, where access to affordable and quality health care has never been more vital.…

Find out more »

2020 ASM Conference on Next-Generation Sequencing

December 7, 2020 - December 11, 2020
VIRTUAL EVENT

Join us at the virtual 2020 ASM Conference on Next-Generation Sequencing, taking place Dec. 7-11, 2020, and get comprehensive guidance with up-to-date examples in the use of NGS technology for applied results in the traceability and clustering of microbial pathogens associated with food safety, clinical infection, environmental contamination and other potential sources of disease outbreaks. You’ll walk away with access to the available resources and direction you need relating to bioinformatics and epidemiology. Click here to learn more. Click here to view…

Find out more »

BLUE KNIGHT™ Symposium

December 8, 2020 - December 10, 2020
Virtual Event, 765 Commonwealth Avenue
Boston, MA 02215 United States
+ Google Map

CARB-X participants include Erin Duffy, Chief of R&D. Johnson & Johnson Innovation – JLABS is collaborating with the Biomedical Advanced Research and Development Authority (BARDA), a component of the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services, to form Blue Knight. This collaboration aims to stimulate innovation and incubation of technologies that improve health security and response through companies focused on public health threats and emerging infectious diseases. Find out more…

Find out more »

January 2021

National Academy of Science

January 5
VIRTUAL EVENT

The National Academy of Sciences (NAS) is a private, nonprofit organization of the country’s leading researchers. The NAS recognizes and promotes outstanding science through election to membership; publication in its journal, PNAS; and its awards, programs, and special activities. Through the National Academies of Sciences, Engineering, and Medicine, the NAS provides objective, science-based advice on critical issues affecting the nation. CARB-X participants include Kevin Outterson, Executive Director. Click here to learn more.

Find out more »

Live Webinar: GARDP/REVIVE – Manipulating the host response to treat infections

January 14 @ 11:00 am - 12:30 pm
WEBINAR Webinar, Webinar United States + Google Map

Immune modulation and host directed therapies as an adjunctive approach to treating infections (R.E.W. (Bob) Hancock): Host defence peptides (HDP; often termed antimicrobial peptides) stimulate protective immunity while suppressing potentially harmful inflammation. Both of these activities can assist in anti-infective therapy. HDPs work as immune modulators in animal models against ESKAPE pathogen, MDR TB, fungal, malaria and viral infections, as well as sterile inflammation. They are likely to be employed in adjunctive therapy in combination with antibiotics. HDPs often have…

Find out more »
+ Export Events